Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank14
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P14
Within normal range
vs 5Y Ago
-5.3x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
2025-45.38%+5.5%
2024-48.00%-43.0%
2023-33.58%-9.4%
2022-30.70%-161.2%
2021-11.75%-236.4%
20208.61%+1784.9%
2019-0.51%+80.2%
2018-2.59%-